Literature DB >> 3265676

Interleukin-5: an eosinophil growth and activation factor.

C J Sanderson1.   

Abstract

A mouse lymphokine stimulating eosinophil differentiation has been identified and characterized. This factor was found to be identical to B cell growth factor II, and is now called interleukin-5 (IL5). Although this murine factor stimulated human eosinophil differentiation and activation, it had no detectable activity on human B cells. Following the cloning of the mouse factor, the human gene was cloned and expressed. Like the mouse factor human IL5 stimulates the production and activation of human eosinophils. However, unlike mouse IL5 which has a readily detectable activity on murine B cells, the human factor was negative when tested in a variety of assays on human B cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265676

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  17 in total

1.  Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.

Authors:  Zhenmei Lu; Soosan Ghazizadeh
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

2.  Experimental Modeling of Eosinophil-Associated Diseases.

Authors:  Sathisha Upparahalli Venkateshaiah; Murli Manohar; Hemanth Kumar Kandikattu; Anil Mishra
Journal:  Methods Mol Biol       Date:  2021

3.  SATB1 dictates expression of multiple genes including IL-5 involved in human T helper cell differentiation.

Authors:  Helena Ahlfors; Amita Limaye; Laura L Elo; Soile Tuomela; Mithila Burute; Kamal Vishnu P Gottimukkala; Dimple Notani; Omid Rasool; Sanjeev Galande; Riitta Lahesmaa
Journal:  Blood       Date:  2010-06-03       Impact factor: 22.113

4.  Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.

Authors:  Harvey E Johnston; Matthew J Carter; Kerry L Cox; Melanie Dunscombe; Antigoni Manousopoulou; Paul A Townsend; Spiros D Garbis; Mark S Cragg
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

5.  Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.

Authors:  Sara A Paveglio; Jenna Allard; Samantha R Foster Hodgkins; Jennifer L Ather; Mieke Bevelander; Jana Mayette Campbell; Laurie A Whittaker LeClair; Sean M McCarthy; Albert van der Vliet; Benjamin T Suratt; Jonathan E Boyson; Satoshi Uematsu; Shizuo Akira; Matthew E Poynter
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-29       Impact factor: 6.914

6.  Aspergillus antigen-induced eosinophil differentiation in a murine model.

Authors:  P S Murali; G Dai; A Kumar; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 7.  IgE immunotherapy against cancer.

Authors:  Lai Sum Leoh; Tracy R Daniels-Wells; Manuel L Penichet
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

8.  Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.

Authors:  P Kernen; M P Wymann; V von Tscharner; D A Deranleau; P C Tai; C J Spry; C A Dahinden; M Baggiolini
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

9.  Role of eosinophils in the initiation and progression of pancreatitis pathogenesis.

Authors:  Murli Manohar; Alok K Verma; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-09-21       Impact factor: 4.052

10.  Early exposure of infants to GI nematodes induces Th2 dominant immune responses which are unaffected by periodic anthelminthic treatment.

Authors:  Victoria J Wright; Shaali Makame Ame; Haji Said Haji; Rosemary E Weir; David Goodman; David I Pritchard; Mahdi Ramsan Mohamed; Hamad Juma Haji; James M Tielsch; Rebecca J Stoltzfus; Quentin D Bickle
Journal:  PLoS Negl Trop Dis       Date:  2009-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.